1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Deargen | Protai |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2021 |
| Headquarters | ||
| Headquarters | Daejeon, Korea South | Israel |
| Employees | ||
| Employees | 11 | 29 |
| Industry | ||
| Industry | AI, Biotechnology, Machine Learning | AI, Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Seed |
| Total Funding | ||
| Total Funding | $23.00B | $20.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Services | ||
| Services | AI Platform for Drug Discovery, New Drug Development, Molecular Optimization, Target Affinity Prediction, Toxicity-Centered Drug Design | Structural Proteomics Integration, AI-Driven Drug Discovery, Pipeline Development, End-to-End Drug Discovery Collaboration, AIMS™ Platform Utilization |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Firms, Medical Research Institutions, Drug Development Organizations, AI-Driven Healthcare Providers | Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Innovators, Partnering Enterprises |
| Taxonomy | ||
| Taxonomy | AI-driven Drug Discovery, Sequence-based Drug Development, Transformer Technology In Pharmaceuticals, Hit/Lead Compound Discovery, End-to-end AI Solution, Biotechnology Innovation, Genome Analysis Service, Deep Learning In Pharma, Computational Chemistry, Medicinal Chemistry, Target Discovery, Lead Optimization, AI In Healthcare, Pharmatech Innovation, Drug Design And Development | Proteomics, AI Drug Discovery, End-to-End AI Platform, Cellular Function Analysis, Biological Insights, Complex Disease Combat, Protein Level Mapping, Drug Candidate Creation, Drug Discovery Facilitation, Advanced Drug Discovery, Disease Mapping, Molecular Biology, Pharmaceutical Innovation, Biotech |
| Website | ||
| Website | deargen.me | protai.bio |
About Deargen
Deargen, founded in 2016, positions itself as a pioneer in the intersection of AI and pharmaceuticals. This AI-First Pharmatech Company focuses on revolutionizing drug discovery and development through sequence-based AI solutions. Headquartered in Korea South, the company leverages advanced AI, part...
About Protai
Protai, founded in 2021 and headquartered in Israel, leverages cutting-edge technologies in AI, Biotechnology, and Life Sciences to revolutionize drug discovery. By utilizing an AI-based platform, Protai delves into the proteomic landscape to map diseases at the protein level, offering a novel appro...
We will tell you when either one moves
BounceWatch watches Deargen and Protai for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Deargen and Protai — by email.
Frequently Asked Questions
Compare Deargen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Deargen on 15 Jun 2026, and Protai on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.